Interleukin 17 induces up-regulation of chemokine and cytokine expression via activation of the nuclear factor κB and extracellular signal-regulated kinase 1/2 pathways in gynecologic cancer cell lines

International Journal of Gynecological Cancer

Volumn 21, Issue 9, 2011, Pages 1533-1539

  Lai, Ting ^a   Wang, Kana ^a   Hou, Qiannan ^a   Zhang, Jian ^a   Yuan, Jialing ^a   Yuan, Lixing ^a   You, Zongbing ^b   Xi, Mingrong ^a  

^a SICHUAN UNIVERSITY   (China)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; ERK1 2; Gynecologic cancer; IL 17; Nf b

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CXCL2 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; RANTES; CHEMOKINE; CYTOKINE;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; ENDOMETRIUM CANCER; ENZYME ACTIVATION; FEMALE; GYNECOLOGIC CANCER; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; CELL GROWTH; DRUG ANTAGONISM; DRUG EFFECT; FEMALE GENITAL TRACT TUMOR; GENETICS; METABOLISM; PATHOLOGY; STIMULATION; TUMOR CELL LINE;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHEMOKINES; CYTOKINES; FEMALE; GENITAL NEOPLASMS, FEMALE; HELA CELLS; HUMANS; INTERLEUKIN-17; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; RNA, MESSENGER; STIMULATION, CHEMICAL; UP-REGULATION;

EID: 84863251006     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822d2abd     Document Type: Article

References (20)

1. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of TH1 and TH17 T cells. J Invest Dermatol. 2008;128:1207-1211. (Pubitemid 351543220)
2. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;11:1133-1141. (Pubitemid 41541791)
3. Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;175: 6177-6189. (Pubitemid 41508106)
4. Pongcharoen S, Niumsup P, Sanguansermsri D, et al. The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells. Am J Reprod Immunol. 2006;55:291-300. (Pubitemid 43349265)
5. Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood. 2003;101:2620-2627. (Pubitemid 36857622)
6. Benchetrit F, Ciree A, Vives V, et al. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood. 2002;99:2114-2121. (Pubitemid 34525496)
7. Jones GL, Ledger W, Bonnett TJ, et al. The impact of treatment for gynecological cancer on health-related quality of life (HRQoL): a systematic review. Am J Obstet Gynecol. 2006;194:26-42. (Pubitemid 43017772)
8. Tartour E, Fossiez F, Joyeux I, et al. Interleukin-17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 1999;59:3698-3704. (Pubitemid 29381875)
9. Kryczek I, Banerjee M, Cheng PL, et al. Phenotype, distribution, generation, and functional and clinical relevance of TH17 cells in the human tumor environments. Blood. 2009;114:1141-1149.
10. Kato T, Furumoto H, Ogura T, et al. Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Comm. 2001;282: 735-738. (Pubitemid 32924619)
11. Goswami B, Rajappa M, Sharma M, et al. Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies. Int J Gynecol Cancer. 2008;18:591-599. (Pubitemid 352020177)
12. Kulbe H, Thompson R, Wilson JL, et al. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 2007;67:585-592. (Pubitemid 46192196)
13. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol. 2006;6:329-333.
14. Qiu Z, Dillen C, Hu J, et al. Interleukin-17regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology. 2009;214:835-842.
15. Zrioual S, Toh ML, Tournadre A, et al. IL-17RA and IL-17RC receptors are essential for IL-17A-Induced ELR+CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J Immunol. 2008;180:655-663.
16. Sebkova L, Pellicano A, Monteleone G, et al. Extracellular signal regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect Immun. 2004;72:5019-5026. (Pubitemid 39223385)
17. Tanabe O, Akira S, Kamiya T, et al. Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. J Immunol. 1988;141:3875-3881.
18. Rahman MS, Yang J, Shan LY, et al. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin Immunol. 2005;115:268-276. (Pubitemid 40712322)
19. Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem. 1998;273:27467-27473. (Pubitemid 28500465)
20. Laan M, Lötvall J, Chung KF, et al. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol. 2001;133:200-206. (Pubitemid 32500468)